Recombinant Human NRG2 protein (GST tag N-Terminus)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human NRG2 protein (GST tag N-Terminus) is a Human Fragment protein, in the 116 to 215 aa range, expressed in Wheat germ, suitable for ELISA, WB.
View Alternative Names
NTAK, NRG2, Pro-NRG2
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human NRG2 protein (GST tag N-Terminus) (AB152998)
ab152998 on a 12.5% SDS-PAGE stained with Coomassie Blue.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
NRG2 is involved in neural development and synaptic plasticity. It associates with ErbB receptor tyrosine kinases to mediate cellular responses. NRG2 forms a complex with these receptors to trigger downstream signaling pathways that support nerve cell growth and repair. As a ligand it selectively binds to ErbB3 and ErbB4 initiating pathways important for brain homeostasis and function.
Pathways
The NRG2 protein plays a significant role in the PI3K/AKT signaling and MAPK/ERK pathways. These pathways are essential for regulating cell survival proliferation and differentiation. Through the ErbB receptors NRG2 influences these signaling pathways intimately connecting it with other proteins such as AKT1 in the PI3K/AKT pathway and MEK1/2 in the MAPK/ERK pathway which further amplify its regulatory roles in cellular processes.
Specifications
Form
Liquid
General info
Function
Direct ligand for ERBB3 and ERBB4 tyrosine kinase receptors. Concomitantly recruits ERBB1 and ERBB2 coreceptors, resulting in ligand-stimulated tyrosine phosphorylation and activation of the ERBB receptors. May also promote the heterodimerization with the EGF receptor.
Sequence similarities
Belongs to the neuregulin family.
Post-translational modifications
Proteolytic cleavage close to the plasma membrane on the external face leads to the release of the soluble growth factor form.. Extensive glycosylation precedes the proteolytic cleavage.
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com